|
1. GLP-1s and cancer outcomes: What new research shows Full story
2. Parkinson’s drug development halted after midstage trial failure Full story
3. $20Kâ$60K per infection: Why ASC sterile processing gaps threaten margins and compliance here.
4. Eli Lilly’s landmark GLP-1 results change the weight loss treatment calculus Full story
5. Can Epic get any bigger? Full story
6. Patients quietly disappear after referrals and no-shows. See the tech fixing outreach gaps here.
7. FDA approves 1st chronic HDV treatment Full story
8. 3 drug safety fronts to watch Full story
Becker’s Learning Opportunities
9. HR, nursing and safety teams are often not aligned on de-escalation training. Fix that here.
10. Staffing challenges often trace to a handful of units. Find them before they add up here.
11. Is your health system capturing the full enterprise value of precision genomics? Find out here.
12. Becker’s resources don’t stop here â explore more webinars and whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
